Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0670
+0.0090 (15.52%)
Feb 12, 2026, 11:51 AM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $11.56 million as of February 13, 2026. Its market cap has decreased by -8.55% in one year.
Market Cap
11.56M
Enterprise Value
8.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has decreased from 14.08M to 11.56M, a decrease of -17.86%. That is a compound annual growth rate of -0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 11.56M | 48.89% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 13.63M |
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |
| Biomind Labs | 8.84M |
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.75M |
| BetterLife Pharma | 7.44M |
| Synlogic | 7.17M |